Thrifty Merrimack developing new cancer drugs at lower cost
By Bill Berkrot NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipe...
Read More »By Bill Berkrot NEW YORK (Reuters) - Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipe...
Read More »(Reuters) - Montreal, Canada's second-largest city, has asked 1.3 million people to boil their drinking water after a problem at one...
Read More »
FRANKFURT (Reuters) - German software company SAP is looking to recruit people with autism as programmers and product testers, drawi...
Read More »(Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main ...
Read More »
By Caroline Copley ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former bio...
Read More »
By Kate Kelland, Health and Science Correspondent LONDON (Reuters) - For a pathogen with such a short history, the mysterious new vi...
Read More »
(Reuters) - Pfizer Inc said on Wednesday it will spin off its majority stake in animal health business Zoetis Inc to shareholders by...
Read More »
By Ben Hirschler LONDON (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with Gla...
Read More »
By Alex Dobuzinskis LOS ANGELES (Reuters) - Los Angeles, which has more storefront medical marijuana shops than any other U.S. city,...
Read More »By Ben Hirschler LONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the...
Read More »